Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults.

As the process of Alzheimer's disease (AD) begins years before disease onset, searching for prevention strategies is of major medical and economic importance. Nutritional supplementation with long-chain polyunsaturated omega-3 fatty acids (LC-n3-FA) may exert beneficial effects on brain structure and function. However, experimental evidence in older adults without clinical dementia is inconsistent, possibly due to low sensitivity of previously employed test batteries for detecting subtle improvements in cognition in healthy individuals. Here we used LOCATO, recently described as a robust and sensitive tool for assessing object-location memory (OLM) in older adults, to evaluate the impact of LC-n3-FA supplementation on learning and memory formation. In a double-blind placebo-controlled proof-of-concept study, 44 (20 female) cognitively healthy individuals aged 50-75 years received either LC-n3-FA (2,200 mg/day, n = 22) or placebo (n = 22) for 26 weeks. Before and after intervention, memory performance in the OLM-task (primary) was tested. As secondary outcome parameters, performance in Rey Auditory Verbal Learning Test (AVLT), dietary habits, omega-3-index, and other blood-derived parameters were assessed. Omega-3 index increased significantly in the LC-n3-FA group compared with the placebo group. Moreover, recall of object locations was significantly better after LC-n3-FA supplementation compared with placebo. Performance in the AVLT was not significantly affected by LC-n3-FA. This double-blind placebo-controlled proof-of-concept study provides further experimental evidence that LC-n3-FA exert positive effects on memory functions in healthy older adults. Our findings suggest novel strategies to maintain cognitive functions into old age.

[1]  D. Delis,et al.  California Verbal Learning Test--Second Edition , 2016 .

[2]  A. Villringer,et al.  Components of a Mediterranean diet and their impact on cognitive functions in aging , 2015, Front. Aging Neurosci..

[3]  D. Alexander,et al.  Docosahexaenoic Acid and Adult Memory: A Systematic Review and Meta-Analysis , 2015, PloS one.

[4]  Shankuan Zhu,et al.  Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials. , 2014, The American journal of clinical nutrition.

[5]  C. Breitenstein,et al.  An object location memory paradigm for older adults with and without mild cognitive impairment , 2014, Journal of Neuroscience Methods.

[6]  Lucia Kerti,et al.  Long-chain omega-3 fatty acids improve brain function and structure in older adults. , 2014, Cerebral cortex.

[7]  W. Stonehouse Does Consumption of LC Omega-3 PUFA Enhance Cognitive Performance in Healthy School-Aged Children and throughout Adulthood? Evidence from Clinical Trials , 2014, Nutrients.

[8]  T. Nettelbeck,et al.  Cognitive performance in older adults is inversely associated with fish consumption but not erythrocyte membrane n-3 fatty acids. , 2014, The Journal of nutrition.

[9]  D. Rujescu,et al.  Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2013, Neurology.

[10]  C. D. de Jager,et al.  Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer’s disease , 2013, Journal of clinical and experimental neuropsychology.

[11]  M. Lavialle,et al.  Omega-3 fatty acids and brain resistance to ageing and stress: Body of evidence and possible mechanisms , 2013, Ageing Research Reviews.

[12]  A. Chin,et al.  Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial , 2013, Psychopharmacology.

[13]  Cai Song,et al.  Cognitive enhancement by omega-3 fatty acids from child-hood to old age: Findings from animal and clinical studies , 2013, Neuropharmacology.

[14]  K. Radeborg,et al.  Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study , 2012, Nutrition Journal.

[15]  S. Knecht,et al.  Non-invasive brain stimulation improves object-location learning in the elderly , 2012, Neurobiology of Aging.

[16]  Sarah A. Chau,et al.  Effects of omega-3 fatty acids on cognitive performance: a meta-analysis , 2012, Neurobiology of Aging.

[17]  A. Dangour,et al.  Omega 3 fatty acid for the prevention of cognitive decline and dementia , 2012, The Cochrane database of systematic reviews.

[18]  L. Downey,et al.  The effects of 90-day supplementation with the Omega-3 essential fatty acid docosahexaenoic acid (DHA) on cognitive function and visual acuity in a healthy aging population , 2012, Neurobiology of Aging.

[19]  D. Mozaffarian,et al.  Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. , 2011, Journal of the American College of Cardiology.

[20]  T. Nettelbeck,et al.  The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: A randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults , 2011, Nutrition journal.

[21]  J. Buckley,et al.  Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial , 2011, British Journal of Nutrition.

[22]  R. Mayeux,et al.  Epidemiology of Alzheimer disease , 2011, Nature Reviews Neurology.

[23]  Yael Steinhart,et al.  The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study , 2010, Clinical interventions in aging.

[24]  A. Blackwell,et al.  Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline , 2010, Alzheimer's & Dementia.

[25]  Marcus Richards,et al.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial. , 2010, The American journal of clinical nutrition.

[26]  A. Korczyn,et al.  Phosphatidylserine Containing ω–3 Fatty Acids May Improve Memory Abilities in Non-Demented Elderly with Memory Complaints: A Double-Blind Placebo-Controlled Trial , 2010, Dementia and Geriatric Cognitive Disorders.

[27]  H. Su Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. , 2010, The Journal of nutritional biochemistry.

[28]  Libin Cui,et al.  Improved spatial learning performance of fat-1 mice is associated with enhanced neurogenesis and neuritogenesis by docosahexaenoic acid , 2009, Proceedings of the National Academy of Sciences.

[29]  Vincenzo Paolo Senese,et al.  Visuospatial memory in healthy elderly, AD and MCI: a review. , 2009, Current aging science.

[30]  R. Kessels,et al.  How the brain remembers and forgets where things are: The neurocognition of object–location memory , 2008, Neuroscience & Biobehavioral Reviews.

[31]  A. Beekman,et al.  Effect of fish oil on cognitive performance in older subjects , 2008, Neurology.

[32]  A. Veronica Witte,et al.  Lifestyle and Memory in the Elderly , 2008, Neuroepidemiology.

[33]  D. Snodderly,et al.  Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women , 2008, Nutritional neuroscience.

[34]  J. Petrella,et al.  Prognostic Value of Posteromedial Cortex Deactivation in Mild Cognitive Impairment , 2007, PLoS ONE.

[35]  C. von Schacky,et al.  Omega-3 fatty acids and cardiovascular disease , 2007, Current opinion in clinical nutrition and metabolic care.

[36]  W. Harris,et al.  Cardiovascular benefits of omega-3 fatty acids. , 2007, Cardiovascular research.

[37]  O. Shido,et al.  Docosahexaenoic acid promotes neurogenesis in vitro and in vivo , 2006, Neuroscience.

[38]  Noriyuki Matsukawa,et al.  Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction , 2006, Neuroscience Research.

[39]  J. Billard Ageing, hippocampal synaptic activity and magnesium. , 2006, Magnesium research.

[40]  L. Arterburn,et al.  Distribution, interconversion, and dose response of n-3 fatty acids in humans. , 2006, The American journal of clinical nutrition.

[41]  F. Corradeschi,et al.  Cognitive and physiological effects of Omega‐3 polyunsaturated fatty acid supplementation in healthy subjects , 2005, European journal of clinical investigation.

[42]  J. Morris,et al.  Mild cognitive impairment and preclinical Alzheimer's disease. , 2005, Geriatrics.

[43]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[44]  F. Gomez-Pinilla,et al.  Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[45]  T. Hara,et al.  Improvement of spatial cognition with dietary docosahexaenoic acid is associated with an increase in Fos expression in rat CA1 hippocampus , 2004, Clinical and experimental pharmacology & physiology.

[46]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[47]  S. Hossain,et al.  Chronic Administration Of Docosahexaenoic Acid Improves The Performance Of Radial Arm Maze Task In Aged Rats , 2001, Clinical and experimental pharmacology & physiology.

[48]  N. Nishiyama,et al.  Docosahexaenoic acid improves long‐term potentiation attenuated by phospholipase A2 inhibitor in rat hippocampal slices , 2001, British journal of pharmacology.

[49]  P Weber,et al.  Triglyceride-lowering effect of omega-3 LC-polyunsaturated fatty acids--a review. , 2000, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[50]  K. Wesnes,et al.  Validity and utility of the cognitive drug research (CDR) computerised cognitive testing system: A review following fifteen years of usage , 1999, European Neuropsychopharmacology.

[51]  Romola S. Bucks,et al.  Development and validation of the Location Learning Test (LLT): A test of visuo-spatial learning designed for use with older adults and in dementia , 1997 .

[52]  D. Watson,et al.  Development and validation of brief measures of positive and negative affect: the PANAS scales. , 1988, Journal of personality and social psychology.

[53]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[54]  M. Hashimoto,et al.  Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. , 2011, Journal of pharmacological sciences.

[55]  D. Ma,et al.  Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. , 2009, The Journal of nutritional biochemistry.

[56]  Morris Moscovitch,et al.  Item and associative memory in amnestic mild cognitive impairment: performance on standardized memory tests. , 2008, Neuropsychology.

[57]  I. Frey,et al.  Freiburger Fragebogen zur körperlichen Aktivität-Entwicklung, Prüfung und Anwendung , 2005, Sozial- und Präventivmedizin.